Rehacare Düsseldorf 2026

Rehacare Düsseldorf

International trade fair for rehabilitation, care, prevention and inclusion

Date:
23.09.2026 - 26.09.2026
Wednesday - Saturday, 4 days

0 Days
0 Hours
0 Minutes
0 Seconds

Fair Location
Messe Düsseldorf GmbH
Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

REHACARE Düsseldorf

Where rehabilitation funding compliance is validated — not just devices presented.

This is not a fair for general medical equipment or speculative care concepts.

An occupational therapist evaluates three rehabilitation devices at REHACARE. All present similar features. Nine months later, only the device with Hilfsmittelverzeichnis listing and MDR certification is prescribed to patients.

The difference wasn't the device quality. It was the documented funding eligibility and clinical evidence — and the ability to prove it during the 9–18 month statutory funding cycle that follows every REHACARE.

BHOWCO Strategic Assessment — At BHOWCO, we evaluate trade fairs through buyer behaviour, supplier verification and long-term international positioning rather than exhibition attendance alone. The assessment below reflects the BHOWCO strategic evaluation model.

REHACARE functions as a rehabilitation funding compliance and provision validation platform for the German and European healthcare system. Healthcare providers, occupational therapists and statutory payers evaluate suppliers against Hilfsmittelverzeichnis listing, MDR compliance and clinical evidence — not just device features.

Verified Exhibition Data

  • 900+ Exhibiting Companies (2024)
    Mobility aids, everyday aids, orthopaedic products, communication tech, and rehab solutions
  • 44,000+ Professional Attendees
    Healthcare providers, therapists, caregivers, and people with disabilities
  • World's Leading Rehabilitation Trade Fair
    Global platform for rehabilitation, prevention, inclusion, and care solutions
  • Annual Provision Cycle
    Critical event for aid directory listing and professional network validation

These metrics confirm REHACARE functions as the rehabilitation industry's funding compliance validation platform — where reimbursement eligibility and clinical evidence outweigh product features.

Data source: AUMA – Association of the German Trade Fair Industry

Strategic Snapshot

This is not a medical device exhibition. It is a rehabilitation funding compliance and provision validation platform. Participation signals your capability to provide Hilfsmittelverzeichnis listing, documented clinical evidence for prescription, and MDR compliance for medical devices. Funding compliance carries more weight than device features when healthcare providers evaluate rehabilitation products for patient care.

REHACARE Supplier Ecosystem

The fair attracts a broad cross-section of the rehabilitation industry supply chain. Buyer evaluation criteria vary by supplier type.

Medical Device Manufacturers

  • • Hilfsmittelverzeichnis listing
  • • MDR 2017/745 compliance
  • • Clinical evidence for prescription
  • • Reimbursement code eligibility

Mobility & Daily Living Aids

  • • Prescription eligibility
  • • Safety and usability evidence
  • • Professional training support
  • • Reimbursement compatibility

Orthopaedic & Prosthetic Solutions

  • • MDR certification (Class I/IIa)
  • • Clinical evaluation reports
  • • Fitting and adjustment support
  • • Patient outcome evidence

Communication & Assistive Technology

  • • Prescription pathway
  • • User training and support
  • • Clinical effectiveness data
  • • Funding code eligibility

Exhibits Successfully When

  • Hilfsmittelverzeichnis listing is confirmed
    Evidence expected by professional buyers: German statutory health insurance aid directory listing or documented application
  • MDR compliance documentation is complete
    Evidence expected by professional buyers: Class I/IIa medical device certification under MDR 2017/745
  • Clinical evidence for prescription is available
    Evidence expected by professional buyers: published studies or clinical evaluation supporting intended use
  • You understand 9–18 month funding cycles
    Evidence expected by professional buyers: commitment to reimbursement processes and professional training

Likely To Waste Budget When

  • Hilfsmittelverzeichnis listing is missing → Hard No if: no statutory reimbursement code or documented application
  • Competing on device features alone → Hard No if: funding eligibility and clinical evidence are secondary
  • MDR certification is incomplete → Hard No if: medical device regulatory documentation is missing
  • Expecting immediate patient sales → Hard No if: goal bypasses professional prescription and funding approval

Strategic recommendation: If two or more Hard No conditions apply, reconsider exhibiting until those gaps are addressed.

Strategic Decision Checkpoint

Based on the BHOWCO strategic evaluation model: If you meet fewer than 3 of the 4 "Exhibits successfully when" criteria, REHACARE becomes a marketing expense rather than a rehabilitation market entry strategy.

Market reality adjustment:

  • Meet 3–4 criteria (with Hilfsmittelverzeichnis listing): REHACARE accelerates integration into statutory health insurance provision.
  • Meet 3–4 criteria (new to German rehab market): Requires 12–18 month lead time for MDR certification, aid directory listing, and clinical validation.
  • Meet 0–2 criteria: Achieve MDR compliance and reimbursement listing first. Exhibit after securing statutory approval.

4-Day Presence vs 12-Month Decision Cycle

REHACARE provides 4 days of concentrated funding evaluation. The German rehabilitation industry operates on 9–18 month funding approval and prescription timelines.

Evidence of progress: Hilfsmittelverzeichnis verification requested 3–6 months post-fair for prescribing network inclusion.

Evidence of failure: No request for funding documentation or clinical evidence within 90 days.

Maintaining continuous market presence after the exhibition separates rehabilitation suppliers from statutory funding partners.

Why Post-Fair Presence Matters in Rehabilitation Procurement

A strong exhibition meeting establishes product relevance. It does not complete funding approval. During the months that follow, healthcare providers and statutory payers continue comparing clinical evidence, regulatory documentation and reimbursement eligibility.

The supplier that remains credible and verifiable during this evaluation period protects more of the value created at the exhibition.

Practical Information

  • 📅Dates: 23–26 September 2026
  • 📍Venue: Messe Düsseldorf, Düsseldorf, Germany
  • 🏛️Established: 1977
  • 🔄Cycle: annual
  • 🏭Focus: Rehabilitation, Care, Mobility Aids, Orthopaedics, Inclusion
  • 🏢Organizer: Messe Düsseldorf GmbH
  • 📞Phone: +49 211 4560-01
  • ✉️Email: info@messe-duesseldorf.de
  • 🌐Website: rehacare.com

BHOWCO Strategic Position Score — REHACARE

This score evaluates your company's strategic position for REHACARE based on buyer behaviour, market conditions, and documentation readiness.

Recommended if:

  • ✓ You have Hilfsmittelverzeichnis listing or documented application
  • ✓ MDR compliance documentation is complete
  • ✓ Clinical evidence for prescription is available

Reconsider if:

  • ✕ Device features are your only competitive advantage
  • ✕ Funding eligibility and clinical evidence are undocumented
  • ✕ Your primary objective is immediate patient sales
Score Methodology
Funding Compliance Readiness: Very High Regulatory Documentation: High Clinical Evidence Requirement: High Post-Fair Evaluation Importance: Very High
BHOWCO Evaluation Model
87/100
Based on the BHOWCO strategic evaluation model for rehabilitation exhibitions Decision Framework v2.0

✓ If You Are Ready for REHACARE

The exhibition becomes an opportunity to:

  • Strengthen buyer confidence through Hilfsmittelverzeichnis listing
  • Accelerate supplier evaluation with verifiable MDR compliance
  • Support prescribing decisions with clinical evidence
  • Build long-term market presence in the rehabilitation sector

CEO Takeaway

If your company cannot demonstrate funding eligibility and clinical evidence, the exhibition itself will not create competitive advantage.

Strategic FAQs

Is REHACARE the right exhibition for every rehabilitation supplier?

Not necessarily. The fair's healthcare audience evaluates products based on documented funding eligibility and clinical evidence. Suppliers unable to provide verifiable reimbursement data often find the investment produces limited return compared to competitors who can demonstrate proven statutory health insurance listing.

What happens after REHACARE ends?

Buyer evaluation continues through supplier comparison, clinical evidence review, and internal procurement processes. The 9–18 month funding cycle means decisions are rarely made during the exhibition itself. Maintaining a professional presence during this period often influences long-term purchasing decisions.

Why doesn't exhibiting guarantee business?

REHACARE functions as a qualification platform where buyers identify suppliers for further evaluation. Most prescribing decisions require additional clinical evidence review and funding verification after the exhibition. Exhibiting without documented reimbursement eligibility limits your ability to progress through buyer qualification processes.

What documentation do rehabilitation buyers require?

Three critical areas: 1) Hilfsmittelverzeichnis listing or documented application, 2) MDR 2017/745 compliance documentation, 3) Clinical evidence for prescription and efficacy. Missing documentation often results in immediate prescribing network exclusion.

Final decision filter: Exhibit at REHACARE or allocate resources elsewhere?

Exhibit if: 1) Hilfsmittelverzeichnis listing is confirmed, 2) MDR compliance is complete, 3) You understand German funding cycles. Otherwise, allocate resources to: 1) Completing MDR certification, 2) Securing aid directory listing, 3) Building clinical evidence before exhibition.

BHOWCO Readiness Score — REHACARE

This is a readiness assessment, not an exhibition rating. It evaluates your company's preparedness for REHACARE based on the BHOWCO strategic evaluation model.

Buyer Fit — Healthcare Provision Alignment ★★★★★
Market Readiness — German Rehabilitation Sector ★★★★☆
Funding Validation — Hilfsmittel & MDR Evidence ★★★★★
Immediate Sales Potential — Exhibition Conversion ★☆☆☆☆
Long-Term Opportunity — Market Positioning ★★★★★

The readiness score helps you evaluate your exhibition preparedness. Based on the BHOWCO strategic evaluation model.

Is Your Company Ready for REHACARE?

Membership is reviewed. Not all applicants are approved.

Request a strategic consultation via ticket

Professional Reference Notice
Information related to REHACARE may change. While every effort is made to keep this page accurate, exhibitors should always verify details directly via the official exhibition website or organizer channels.

REHACARE Düsseldorf infographic showing assistive technology, professional validation, market access and the B2B journey to long-term adoption

Infographic: REHACARE Düsseldorf Professional Adoption Journey — from assistive technology discovery and professional validation to market access, provider evaluation and long-term adoption. © BHOWCO Trading GmbH. Source: REHACARE Düsseldorf Strategic Exhibitor Guide. Reuse permitted with attribution and a link to the original source.

Official overview of REHACARE Düsseldorf by the organizer

(watch to undrestand the scale. Read below to undrestand how to win as an exhibitor.)

Strategic Analysis for Rehabilitation Technology Suppliers

The official narrative focuses on independent living. The strategic reality for B2B suppliers is funding compliance and provision validation.

REHACARE's Real Function

Serves as the rehabilitation industry's funding compliance and provision validation platform — where healthcare providers and statutory payers verify aid directory listing, MDR compliance and clinical evidence, not just evaluate rehabilitation devices. The evaluation criteria vary by supplier type — medical device manufacturers, mobility aid suppliers, orthopaedic solution providers and assistive technology companies all face different regulatory and funding requirements.

Critical Funding Compliance Signals

  • Hilfsmittelverzeichnis listing or documented application status
  • MDR 2017/745 technical documentation (Class I/IIa certification)
  • Clinical evidence for prescription efficacy and intended use

Additional requirements apply for orthopaedic, prosthetic and assistive technology solutions — patient outcome evidence and professional training support are equally critical.

Strategic Participation Red Line

If funding listing is missing or MDR certification is incomplete → becomes a product showcase, not a credible statutory provision strategy.

Commercial Progress vs. Exclusion

Progress: Funding documentation requested and prescribing network validation initiated for statutory provision.

Exclusion: No follow-up on reimbursement verification or clinical evidence within a reasonable period following the fair.

Exhibit at REHACARE only if:

  • Products have Hilfsmittelverzeichnis listing or documented application
  • MDR compliance documentation is complete and audit-ready
  • You understand German funding and provision cycles

Otherwise: Complete MDR certification first → secure aid directory listing → build clinical evidence → then exhibit with statutory provision intent.

🚀

Worried About Vanishing After the Trade Show?

Most international exhibitors disappear after 3-5 days. We help you use German trade fairs as a strategic launchpad to build a 365-day visibility system that builds lasting credibility.

Before: Strategic preparation & credibility building
During: Multi-channel presence beyond the physical booth
After: Systematic follow-up for continuous authority
📅Free Consultation on the 365-Day System

Transform exhibitions into a measurable strategic process.